VerdePharma
0896.133.411 · rovalta.com · 24/09/2026
NORMAL SITUATION
VerdePharma
Company — Normal situation.
Financial year 2022 · Closed on 31/12/2022
Net result-717,5 k €-1 773,5 %over 1 year
Gross margin-55,1 k €-209,7 %over 1 year
Equity-641,3 k €-942,2 %over 1 year
Overview
Identity
Source · BCE/KBOVerdePharma is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0896.133.411
- Legal form
- Private company with limited liability
- Contributed capital
- 532 000,00 €
- Latest accounts
- 31/12/2022
Joint committees (2)
- 200
- 218
Financials
Source · NBB, 14 filingsTrend over 13 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -55,1 k € | -210% | 50,2 k € | +210% | 16,2 k € | -40.4% | 27,2 k € | +164% | -42,4 k € |
| EBITDA | -284,8 k € | -1131% | 27,6 k € | +127% | -104 k € | -518% | 24,9 k € | +143% | -57,2 k € |
| Operating result | -593,1 k € | -2813% | -20,4 k € | +79.9% | -101,5 k € | -545% | -15,7 k € | +72.8% | -57,8 k € |
| Net result | -717,5 k € | -1773% | -38,3 k € | +63.3% | -104,4 k € | -475% | -18,2 k € | +69.3% | -59,2 k € |
| Balance sheet | |||||||||
| Equity | -641,3 k € | -942% | 76,2 k € | -33.5% | 114,4 k € | -47.7% | 218,8 k € | -7.7% | 237 k € |
| Total assets | 31,3 k € | -95.0% | 622,9 k € | -2.9% | 641,6 k € | -34.9% | 986 k € | +78.5% | 552,4 k € |
| Cash | 694,2 € | -90.0% | 7 k € | +130% | 3 k € | -80.6% | 15,5 k € | +21.1% | 12,8 k € |
| Debts | 672,6 k € | +23.0% | 546,7 k € | +3.7% | 527,2 k € | -31.3% | 767,1 k € | +143% | 315,4 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20221 active · 6 ended
Active mandates
Active
Ended mandates
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/10/2024 | 16/02/2023 | 26/01/2023 | 16/07/2021 | 15/07/2021 | 30/09/2019 |
| General meeting | 09/10/2024 | 15/02/2023 | 25/01/2023 | 29/05/2020 | 13/07/2021 | 18/09/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2022 | 09/10/2024 | 10/10/2024 | Dutch | |
| Abridged model | 31/12/2021 | 15/02/2023 | 16/02/2023 | Dutch | |
| Abridged model | 31/12/2020 | 25/01/2023 | 26/01/2023 | Dutch | |
| Micro model | 31/12/2019 | 29/05/2020 | 16/07/2021 | Dutch | |
| Micro model | 31/12/2018 | 13/07/2021 | 15/07/2021 | Dutch | |
| Micro model | 31/12/2017 | 18/09/2019 | 30/09/2019 | Dutch | |
| Micro model | 31/12/2016 | 05/06/2018 | 16/06/2018 | Dutch | |
| Abridged model | 31/12/2015 | 30/09/2016 | 27/04/2017 | Dutch | |
| Abridged model | 31/12/2014 | 28/09/2015 | 30/09/2015 | Dutch | |
| Abridged model | 31/12/2013 | 31/07/2014 | 29/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 01/08/2013 | 30/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 27/09/2012 | 28/09/2012 | Dutch | |
| Abridged model | 31/12/2010 | 10/10/2011 | 11/10/2011 | Dutch | |
| Abridged model | 31/12/2009 | 28/05/2010 | 25/06/2010 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20221 active · 6 ended
Active mandates
Active
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022-717,5 k €↓
- 2021Annual accounts 2021-38,3 k €↑
- 2020Annual accounts 2020-104,4 k €↓
- 2019Annual accounts 2019-18,2 k €↑
- 2018Annual accounts 2018-59,2 k €↓
- 2017Annual accounts 201741,9 k €↑
- 2016Annual accounts 201623,8 k €↑
- 2014Annual accounts 201416,5 k €↑
- 2013Annual accounts 201312,8 k €↑
- 2012Annual accounts 2012-4,8 k €↑
- 2011Annual accounts 2011-145,2 k €↑
- 2010Annual accounts 2010-148,1 k €↓
- 2009Annual accounts 2009-45,7 k €